Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Haemophilia Market. The market of Global Haemophilia has been analyzed By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S, Canada, Germany, U.K, Japan, China, India and Brazil). The Global Haemophilia market has been assessed for the historical period of 2013-2017 and the forecast period of 2018-2023.
According to Azoth Analytics research report "Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) - By Region (North America, Europe, Asia-Pacific, Rest of the World), By Country (U.S, Canada, Germany, United Kingdom, Japan, China, India, Brazil)", the global Haemophilia market is projected to display a modest growth represented by a CAGR of 6.84% during 2018 - 2023.
Over the recent years, global haemophilia market has been witnessing growth, on account of several driving factors including increasing life expectancy of hemophiliac patients, reduction in inhibitor formation in severe haemophilia cases and new emerging therapies for treatment of haemophilia. Moreover, increasing per capita healthcare expenditure and growing incidences of hemorrhages, arthropaedic and dental surgeries, epistaxis, laceration and abrasion is expected to propel the demand for haemophilia market. In this research report, the market is segmented on the basis of type and treatment. By type, the segment of haemophilia A is predicted to hold its dominant position in the market. Amongst the regions, North America accounts for the largest regional share in the global endoscopy devices market in 2018. However, Asia Pacific is predicted to advance at the highest rate. Presence of vast consumer base, particularly in emerging nations such as China and India, in addition to growing per capita expenditure on healthcare is likely to drive the regional market.
The report titled "Global Haemophilia Market, By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) - By Region (North America, Europe, Asia-Pacific, Rest of the World), By Country (U.S, Canada, Germany, United Kingdom, Japan, China, India, Brazil)" has covered and analyzed the potential of global haemophilia market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global haemophilia market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Haemophilia Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Haemophilia Market - Size, Growth, Forecast
• By Type -Haemophilia A, Haemophilia B
• By Treatment- On- demand, Prophylaxis
Regional Markets - North America, Europe, Asia-Pacific, ROW (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Haemophilia Market - Size, Growth, Forecast
• By Type -Haemophilia A, Haemophilia B
• By Treatment- On- demand, Prophylaxis
Country Analysis - U.S., Canada, Germany, U.K, Japan, India, China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Haemophilia Market - Size, Growth, Forecast
• By Type -Haemophilia A, Haemophilia B
• By Treatment- On- demand, Prophylaxis
Other Report Highlights
• Market Dynamics - Drivers and Restraints
• Market Trends
• Company Share Analysis
• SWOT Analysis
• Porter Five Force Analysis
• Supply Chain Analysis
• Competitive Landscape
• Policy and Regulatory Landscape
• Company Analysis - Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Shire, CSL Behring, Alnylam Pharmaceuticals .
Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Haemophilia Outlook
5. Global Haemophilia Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Haemophilia Market: Segment Analysis
6.1 Global Haemophilia Market Size, By Type: Breakdown (%)
6.1.1 Global Haemophilia Market Size, By Type, 2017 (%)
6.1.2 Global Haemophilia Market Size, By Type, 2023 (%)
6.2 Global Haemophilia A Market, By Value (2013-2023)
6.3 Global Haemophilia B Market, By Value (2013-2023)
6.4 Global Haemophilia Market Size, By Treatment: Breakdown (%)
6.4.1 Global Haemophilia Market Size, By Treatment, 2017 (%)
6.4.2 Global Haemophilia Market Size, By Treatment, 2023 (%)
6.5 Global On- demand Haemophilia Market, By Value (2013-2023)
6.6 Global Prophylaxis Market, By Value (2013-2023)
7. Global Haemophilia Market: Regional Analysis
7.1 Global Haemophilia Market Size, By Region : Breakdown (%)
7.1.1 Global Haemophilia Market Size, By Region, 2017 (%)
7.1.2 Global Haemophilia Market Size, By Region, 2023 (%)
7.2 North America Haemophilia Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Type, By Value (2013-2017)
7.2.4 By Type, By Value (2018-2023)
7.2.5 By Treatment, By Value (2013-2017)
7.2.6 By Treatment, By Value (2018-2023)
7.3 North America Haemophilia Market: Country Analysis (U.S and Canada)
7.3.1 U.S Haemophilia Market, By Value (2013-2023)
7.3.2 U.S Haemophilia Market, By Type, By Value (2013-2017)
7.3.3 U.S Haemophilia Market, By Type, By Value (2018-2023)
7.3.4 U.S Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.5 U.S Haemophilia Market, By Treatment, By Value (2018-2023)
7.3.6 Canada Haemophilia Market, By Value (2013-2023)
7.3.7 Canada Haemophilia Market, By Type, By Value (2013-2017)
7.3.8 Canada Haemophilia Market, By Type, By Value (2018-2023)
7.3.9 Canada Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.10 Canada Haemophilia Market, By Treatment, By Value (2018-2023)
7.4 Europe Haemophilia Market: Growth and Forecast
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Type, By Value (2013-2017)
7.4.4 By Type, By Value (2018-2023)
7.4.5 By Treatment, By Value (2013-2017)
7.4.6 By Treatment, By Value (2018-2023)
7.5 Europe Haemophilia Market: Country Analysis (U.K and Germany)
7.5.1 U.K Haemophilia Market, By Value (2013-2023)
7.5.2 U.K Haemophilia Market, By Type, By Value (2013-2017)
7.5.3 U.K Haemophilia Market, By Type, By Value (2018-2023)
7.5.4 U.K Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.5 U.K Haemophilia Market, By Treatment, By Value (2018-2023)
7.5.6 Germany Haemophilia Market, By Value (2013-2023)
7.5.7 Germany Haemophilia Market, By Type, By Value (2013-2017)
7.5.8 Germany Haemophilia Market, By Type, By Value (2018-2023)
7.5.9 Germany Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.10 Germany Haemophilia Market, By Treatment, By Value (2018-2023)
7.6 APAC Haemophilia Market: Growth and Forecast
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Type, By Value (2013-2017)
7.6.4 By Type, By Value (2018-2023)
7.6.5 By Treatment, By Value (2013-2017)
7.6.6 By Treatment, By Value (2018-2023)
7.7 APAC Haemophilia Market: Country Analysis (Japan, India and China)
7.7.1 Japan Haemophilia Market, By Value (2013-2023)
7.7.2 Japan Haemophilia Market, By Type, By Value (2013-2017)
7.7.3 Japan Haemophilia Market, By Type, By Value (2018-2023)
7.7.4 Japan Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.5 Japan Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.6 India Haemophilia Market, By Value (2013-2023)
7.7.7 India Haemophilia Market, By Type, By Value (2013-2017)
7.7.8 India Haemophilia Market, By Type, By Value (2018-2023)
7.7.9 India Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.10 India Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.11 China Haemophilia Market, By Value (2013-2023)
7.7.12 China Haemophilia Market, By Type, By Value (2013-2017)
7.7.13 China Haemophilia Market, By Type, By Value (2018-2023)
7.7.14 China Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.15 China Haemophilia Market, By Treatment, By Value (2018-2023)
7.8 ROW Haemophilia Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Type, By Value (2013-2017)
7.8.4 By Type, By Value (2018-2023)
7.8.5 By Treatment, By Value (2013-2017)
7.8.6 By Treatment, By Value (2018-2023)
7.9 ROW Haemophilia Market: Country Analysis (Brazil)
7.9.1 Brazil Haemophilia Market, By Value (2013-2023)
7.9.2 Brazil Haemophilia Market, By Type, By Value (2013-2017)
7.9.3 Brazil Haemophilia Market, By Type, By Value (2018-2023)
7.9.4 Brazil Haemophilia Market, By Treatment, By Value (2013-2017)
7.9.5 Brazil Haemophilia Market, By Treatment, By Value (2018-2023)
8. Global Haemophilia Market Dynamics
8.1 Global Haemophilia Market Drivers
8.2 Global Haemophilia Market Restraints
9. Global Haemophilia Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Supply Chain Analysis
13. Competitive Landscape
14. Policy and Regulatory Landscape
15. Company Profiles
15.1 Bayer
15.2 Novo Nordisk
15.3 Pfizer
15.4 Roche
15.5 Aptevo Therapeutics
15.6 Catalyst BioSciences
15.7 Dimension Therapeutics
15.8 Shire
15.9 CSL Behring
15.10 Alnylam Pharmaceuticals
The global Fc Fusion Protein for Haemophilia market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
Overview of the Global Haemophilia Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Haemophilia Therapeutics Market during the forecast period 2023-2030. It pro...
The global Haemophilia Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...
The global Fc Fusion Protein for Haemophilia market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
Summary
The global Haemophilia Treatment market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influenc...
The research team projects that the Haemophilia Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the ...
Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Haemophilia Market. The market of Global Haemophilia has been an...
The Haemophilia Treatment Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Haemophilia Treatment Market. With the use of historic data from (period), the Haemophilia Treatment Market report offers Y-o-Y growth and CAGR until 2026. Th...